• Publications
  • Influence
A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.
BACKGROUND Patients 80 years or older are underrepresented in scientific studies. The objective of this study was to investigate the effectiveness of interventions performed by ward-based pharmacistsExpand
  • 446
  • 25
  • PDF
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST–RA database
Objective: To analyse associations between the clinical status of patients with rheumatoid arthritis (RA) and the gross domestic product (GDP) of their resident country. Methods: The QuantitativeExpand
  • 158
  • 10
  • PDF
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study
IntroductionGender as a predictor of outcomes of rheumatoid arthritis (RA) has evoked considerable interest over the decades. Historically, there is no consensus whether RA is worse in females orExpand
  • 299
  • 9
  • PDF
Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized
Background Appropriateness of prescribing can be assessed by various measures and screening instruments. The aims of this study were to investigate the effects of pharmacists' interventions onExpand
  • 90
  • 6
  • PDF
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study
IntroductionWork disability is a major consequence of rheumatoid arthritis (RA), associated not only with traditional disease activity variables, but also more significantly with demographic,Expand
  • 197
  • 4
Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?
Objectives To assess (A) determinants of patient's global assessment of disease activity (PTGL) and patient's assessment of general health (GH) scores of rheumatoid arthritis (RA) patients; (B)Expand
  • 48
  • 2
Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.
OBJECTIVE Systemic sclerosis (SSc) is a severe connective tissue disease of unknown etiology, characterized by fibrosis of the skin and multiple internal organs. Recent findings suggested that theExpand
  • 89
  • 1
The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA
OBJECTIVES The aim is to assess the prevalence of comorbidities and to further analyse to which degree fatigue can be explained by comorbidity burden, disease activity, disability and gross domesticExpand
  • 46
  • 1
  • PDF
Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database.
OBJECTIVES To analyse clinical severity/activity of rheumatoid arthritis (RA) according to smoking status. METHODS The QUEST-RA multinational database reviews patients for Core Data Set measuresExpand
  • 27
  • 1
Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.
OBJECTIVE We investigated whether vardenafil, a phosphodiesterase-5 inhibitor, alters plasma levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and arginine. PATIENTSExpand
  • 12
  • 1